These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34649997)

  • 1. Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study.
    Kumarendran B; O'Reilly MW; Subramanian A; Šumilo D; Toulis K; Gokhale KM; Wijeratne CN; Coomarasamy A; Tahrani AA; Azoulay L; Arlt W; Nirantharakumar K
    Diabetes Care; 2021 Dec; 44(12):2758-2766. PubMed ID: 34649997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.
    Kumarendran B; O'Reilly MW; Manolopoulos KN; Toulis KA; Gokhale KM; Sitch AJ; Wijeyaratne CN; Coomarasamy A; Arlt W; Nirantharakumar K
    PLoS Med; 2018 Mar; 15(3):e1002542. PubMed ID: 29590099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome.
    Ezeh U; Pisarska MD; Azziz R
    Hum Reprod; 2022 Mar; 37(3):553-564. PubMed ID: 35048126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
    Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML
    Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome.
    Joham AE; Ranasinha S; Zoungas S; Moran L; Teede HJ
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E447-52. PubMed ID: 24081730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.
    Subramanian A; Anand A; Adderley NJ; Okoth K; Toulis KA; Gokhale K; Sainsbury C; O'Reilly MW; Arlt W; Nirantharakumar K
    Eur J Endocrinol; 2021 May; 184(5):637-645. PubMed ID: 33635829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome.
    de Medeiros SF
    Reprod Biol Endocrinol; 2017 Dec; 15(1):93. PubMed ID: 29216881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis.
    Bird ST; Hartzema AG; Brophy JM; Etminan M; Delaney JA
    CMAJ; 2013 Feb; 185(2):E115-20. PubMed ID: 23209115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden.
    Elenis E; Desroziers E; Persson S; Sundström Poromaa I; Campbell RE
    Hum Reprod; 2021 Apr; 36(5):1427-1435. PubMed ID: 33454768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Alesi S; Forslund M; Melin J; Romualdi D; Peña A; Tay CT; Witchel SF; Teede H; Mousa A
    EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
    West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
    Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England.
    Subramanian A; Lee SI; Phillips K; Toulis KA; Kempegowda P; O'Reilly MW; Adderley NJ; Thangaratinam S; Arlt W; Nirantharakumar K
    BMC Med; 2022 Aug; 20(1):298. PubMed ID: 36038914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of disorders of glucose tolerance in women with polycystic ovary syndrome (PCOS) at a tertiary care center: fasting plasma glucose or oral glucose tolerance test?
    Ortiz-Flores AE; Luque-Ramírez M; Fernández-Durán E; Alvarez-Blasco F; Escobar-Morreale HF
    Metabolism; 2019 Apr; 93():86-92. PubMed ID: 30710572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome.
    Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Poromaa IS
    Fertil Steril; 2021 Sep; 116(3):862-871. PubMed ID: 34053678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
    Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
    Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
    Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
    Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
    Chen X; Gissler M; Lavebratt C
    Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.
    Haase CL; Varbo A; Laursen PN; Schnecke V; Balen AH
    Hum Reprod; 2023 Mar; 38(3):471-481. PubMed ID: 36637246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.